HAMILTON, ON, Feb. 20, 2019 /CNW/ - Reliq Health
Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) ("Reliq" or
the "Company"), a technology company that develops
innovative mobile health (mHealth) and telemedicine solutions for
the community-based healthcare market, today announced the
formation of its new Medical Advisory Board and the appointment of
five inaugural members.
"We are pleased to announce the appointment of these
exceptionally accomplished, internationally respected healthcare
innovators to our newly-constituted Medical Advisory Board," said
Dr. Lisa Crossley, CEO of Reliq
Health Technologies. "We look forward to leveraging their
passion for patient care, diverse clinical expertise and extensive
experience with multiple payers and payment models."
"I am excited and honored to be working with such an impressive
group of clinicians, healthcare executives and health policy
experts who share Reliq's commitment to improving health outcomes,
reducing healthcare costs and facilitating access to care for
complex patients in the community," said Dr. Richard Sztramko, MD, FRCPC, Reliq's Chief
Medical Officer and Chair of the Medical Advisory Board.
The five inaugural members of the Medical Advisory Board
are:
Dr. Matthew Finnegan, MD, FACS,
FCCWS – Dr. Finnegan has made considerable contributions to
the art and science of wound healing, helping to develop a
physician-directed, nurse practitioner-managed, patient-centered
wound care model that has become the standard of care. He
currently serves as the Chief, Division of General Surgery at
Lourdes Health System in Camden,
NJ and as a Clinical Associate Professor of Surgery with
Rowan University School of Osteopathic
Medicine. Dr. Finnegan is also the Medical Director of Lourdes
Medical Associates Surgical Specialists and the surgical consultant
at Magee Rehabilitation Center in Philadelphia, PA. He directs the
Lourdes-Magee program to provide care to the most complex wounds in
patients with spinal cord injury. The benefits of this program have
been presented at national and international forums as a model of
clinical excellence. Previously, Dr. Finnegan served as the
Director of the Institute of Wound Healing and Limb Preservation at
Cooper University Hospital in Camden, NJ. He received his MD from
Drexel University College of
Medicine.
Dr. Scott Howell, DO, MA,
MPH&TM, CPE, MBA – Dr. Howell is the Chief Medical
Officer of Vitality Health Plan of California, the first full Knox Keene licensed
Medicare Advantage plan approved by the Department of Managed Care
in California in the last
decade. Previously, Dr. Howell served as CMO for AdvantMed;
Executive Medical Director at Heritage Provider Network; National
Senior Medical Director and CMO for Network and Population Health,
Optum Insight; Regional CMO for the Northeast Region of
Americhoice, Inc. (United Health Group); Medical Director for
Managed Care at the AIDS Healthcare Foundation; and Lead Scientific
Advisor to Management Sciences for Health, the prime contractor for
the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) in
Haiti. Dr. Howell is board
certified in Family Practice, Preventative Medicine and Public
Health and Addiction Medicine. He received his Masters in
Economics from the University of Miami,
Masters in Public Health & Tropical Medicine (MPH&TM) from
Tulane University, MBA from
California State University Fresno and
he is certified by the American College of Physician Executives as
a Certified Physician Executive (CPE).
Mr. Larry Jones – Mr. Jones
is the Chief Executive Officer of HPOF Holdings, LLC, doing
business as Independent Healthcare Partners, located in
Maitland, Florida. He oversees
numerous Independent Practice Associations (IPAs), Management
Services Organizations (MSOs), Medicare Accountable Care
Organizations (ACOs) and IPA Commercial Value-Based Agreements
which are comprised of over 1,000 multi-specialty physicians in 8
counties over the Central Florida
area. Mr. Jones is a founding board member of the Florida
Association of Accountable Care Organizations (FLAACOS) and a
member of the National Association of ACOs (NAACOS). He
served on the Business Advisory Board of Seminole County Public Schools in Florida for 12 years, representing the
insurance committee for over 9000 employees' lives and almost
$60 Million in premiums. Mr.
Jones is a nationally-recognized health policy expert and physician
advocate who regularly publishes and speaks at healthcare forums
across the United States. His background encompasses over 25
years of experience on both the payer and provider side of
healthcare. Mr. Jones' mission is to preserve and protect the
independent practice of medicine.
Dr. Bruce Kinosian, MD – Dr.
Kinosian is a practicing geriatrician at the Cpl Michael J Crescenz
Veterans Affairs Medical Center in Philadelphia, and at the University of Pennsylvania Health System where he
is an Associate Professor of Medicine in the Perelman School of
Medicine. He is also a member of the Board of Directors
of the American Academy of Home Care Medicine (AAHCM), currently
serving as its Treasurer. His research is focused
on the care of medically and socially complex elders in the
community, with an emphasis on integrating care across systems. For
over 20 years, Dr. Kinosian has been involved in economic and
clinical evaluations of both clinical trials and demonstration
projects in delivery of pharmaceuticals and models of care for
complex, multi-morbid elders in both the VA and for those covered
solely by Medicare and Medicaid. He holds a BA in Economics
from Stanford University and an MD from
the University of California, San
Francisco.
Dr. Alexander Stojadinovic, MD,
MBA, FACS – Dr. Stojadinovic is a surgical oncologist with an
impressive mix of healthcare and business expertise. He currently
serves as the Medical Director, Healthcare Management Services for
Amerigroup, Texas, Anthem, Inc.,
one of the leading health plans in the US. Dr. Stojadinovic
previously established and served as Medical Director of the
Complex Wound and Limb Salvage Center at Walter Reed Army Medical
Center (WRAMC), Regional Director of the Bon Secours Cancer
Institute and Vice Chairman, Department of Surgery at WRAMC. He has
built enduring international private-public partnerships to support
innovative research and value-based initiatives, raised over
$30M in research funding, earned four
Professorships and published over 255 peer-reviewed
manuscripts. He is a retired Colonel with the US Army Medical
Corps. Dr. Stojadinovic received his MD from Uniformed Services University of the Health
Sciences, following which he completed his residency in
general surgery at Walter Reed Army Medical Center and a fellowship
in surgical oncology at Memorial Sloan Kettering Cancer Center.
He graduated at the top of his class with a
healthcare-focused Physician Executive MBA from the Nation's
preeminent physician-only degree program at the University of Tennessee-Knoxville's Haslam College of Business.
ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director
ABOUT RELIQ HEALTH
Reliq Health Technologies is a
healthcare technology company that specializes in developing
innovative software solutions for the Community Care market.
Reliq's powerful iUGO Care platform supports care coordination and
community-based healthcare. The iUGO Care platform integrates
wearables, sensors, voice technology and intuitive mobile apps and
desktop user interfaces for patients, clinicians and healthcare
administrators. iUGO Care allows complex patients to receive
high quality care at home, improving health outcomes, enhancing
quality of life for patients and families and reducing the cost of
care delivery. iUGO Care provides real-time access to remote
patient monitoring data, allowing for timely interventions by the
care team to prevent costly hospital readmissions and ER visits.
Reliq Health Technologies trades on the TSX Venture under the
symbol RHT and on the OTCQB as RQHTF.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Cautionary Statements Regarding Forward Looking
Information
Certain statements in this press release constitute
forward-looking statements, within the meaning of applicable
securities laws. All statements that are not historical
facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking statements" involve
known and unknown risks and uncertainties that could cause actual
and future events to differ materially from those anticipated in
such statements.
Forward-looking statements include, but are not limited to,
statements with respect to commercial operations, including
technology development, anticipated revenues, projected size of
market, and other information that is based on forecasts of future
results, estimates of amounts not yet determinable and assumptions
of management.
Reliq Health Technologies Inc. (the "Company") does not
intend and does not assume any obligation, to update these
forward-looking statements except as required by law. These
forward-looking statements involve risks and uncertainties relating
to, among other things, technology development and marketing
activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially
from those expressed or implied by such forward-looking
statements.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/reliq-health-technologies-announces-medical-advisory-board-300798455.html
SOURCE Reliq Health Technologies Inc.